Follow 1st Thoracic Oncology Symposium 2025 for Live Updates
© Copyright 2005 - 2026 MCI Middle East. All Rights Reserved.
Follow 1st Thoracic Oncology Symposium 2025 for Live Updates
It is our great pleasure to welcome you to the 1st Thoracic Oncology Symposium, taking place on 28-29 November in Cleaveland Clinic Abu Dhabi.
As the burden of thoracic malignancies continues to rise globally, the need for multidisciplinary collaboration and innovation has never been greater. This symposium aims to provide a comprehensive platform to explore the latest advances in the diagnosis, treatment, and research of thoracic cancers — from lung, mediastinal and pleural tumors to complex surgical interventions and emerging local and systemic therapies.
Our scientific program features high-impact lectures, expert panels, and interactive sessions led by internationally recognized speakers. It is designed to foster collaboration, stimulate discussion, and inspire excellence in thoracic oncology. We are proud to organize this inaugural edition at Cleveland Clinic Abu Dhabi, and we believe it will serve as a unique opportunity to network, exchange knowledge, and strengthen collaborations across regions and specialties.
We look forward to welcoming you to Abu Dhabi for a meaningful and engaging exchange of ideas — and to shaping the future of thoracic cancer care together.
Best regards,
Gain insights into surgical innovations and multidisciplinary strategies in thoracic oncology care.
Explore the latest advancements in operative approaches to thoracic malignancies.
Enhance your understanding of lung cancer diagnostics and collaborative treatment planning.
Discover evolving techniques in minimally invasive procedures for thoracic tumors.
Stay updated on imaging advancements crucial to early detection and staging of thoracic cancers.
Learn about the role of image-guided therapies in managing complex thoracic oncology cases.
Engage with emerging protocols and precision strategies in radiation therapy for lung cancer.
Deepen your knowledge of systemic therapies and personalized medicine in thoracic oncology.
Understand the intersection of thoracic oncology and transplant-related surgical considerations.
Build a foundational understanding of thoracic oncology through expert-led sessions.
Expand your clinical perspective with evidence-based practices in thoracic cancer care.
Advance your subspecialty training with case-driven insights and expert panel discussions.
Analyse the application of personalised lung cancer care by critically evaluating the latest NCCN guidelines, tumour molecular profiling, and MDT approaches to develop tailored treatment plans that optimise patient outcomes.
Evaluate the efficacy of advanced therapies, including stereotactic body radiotherapy (SBRT), minimally invasive surgical approaches, oncological targeted therapies etc. through the assessment of real case studies to determine their impact on early-stage and complex lung cancer cases.
Synthesise regional and global best practices in lung cancer care by fostering collaboration and networking, enabling attendees to apply these insights to enhance the standard of care and patient access to innovative treatments across the GCC.





Samuel Rangare